Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schauer

Showing results (151-160 of 259) with videos related to

Pageof 26
Sort By:
Geburtshilfe Und Frauenheilkunde|November 1, 1992
[Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients]H Meden, D Marx, W Rath, et al.
Anticancer Research|February 24, 2001
Analysis of the DNA mismatch repair proteins expression in malignant melanomasM Korabiowska, U Brinck, H Dengler, et al.
Radiation Research|July 1, 2006
Retrospective assessment of radiation exposure using biological dosimetry: chromosome painting, electron paramagnetic resonance and the glycophorin a mutation assayR A Kleinerman, A A Romanyukha, D A Schauer, et al.
Inorganic Chemistry|February 27, 2013
Ruthenium(II) complexes bearing a naphthalimide fragment: a modular dye platform for the dye-sensitized solar cellDmitry V Pogozhev, Máté J Bezdek, Phil A Schauer, et al.
Onkologie|August 1, 1987
[Endogenous tumor lectins: new tumor markers and targets in cancer therapy?]H J Gabius, S Gabius, K Vehmeyer, et al.
Anticancer Research|August 15, 1998
Breast preserving surgery decision makingA Schauer, D Marx, M Schauer, et al.
Journal of Obstetrics and Gynaecology (Tokyo, Japan)|April 1, 1995
EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic valueH Meden, D Marx, T Raab, et al.
In Vivo (Athens, Greece)|September 1, 1995
Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesionsM Korabiowska, U Brinck, J Mirecka, et al.
Zentralblatt Fur Chirurgie|January 1, 1992
[Breast carcinoma in pregnancy. Clinical, histological and immunohistochemical findings]H Meden, D Marx, W Rath, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancerD Marx, H Meden, T Ziemek, et al.
Pageof 26

Showing results (151-160 of 259) with videos related to

Sort By:
Pageof 26
Geburtshilfe Und Frauenheilkunde|November 1, 1992
[Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients]H Meden, D Marx, W Rath, et al.
Anticancer Research|February 24, 2001
Analysis of the DNA mismatch repair proteins expression in malignant melanomasM Korabiowska, U Brinck, H Dengler, et al.
Radiation Research|July 1, 2006
Retrospective assessment of radiation exposure using biological dosimetry: chromosome painting, electron paramagnetic resonance and the glycophorin a mutation assayR A Kleinerman, A A Romanyukha, D A Schauer, et al.
Inorganic Chemistry|February 27, 2013
Ruthenium(II) complexes bearing a naphthalimide fragment: a modular dye platform for the dye-sensitized solar cellDmitry V Pogozhev, Máté J Bezdek, Phil A Schauer, et al.
Onkologie|August 1, 1987
[Endogenous tumor lectins: new tumor markers and targets in cancer therapy?]H J Gabius, S Gabius, K Vehmeyer, et al.
Anticancer Research|August 15, 1998
Breast preserving surgery decision makingA Schauer, D Marx, M Schauer, et al.
Journal of Obstetrics and Gynaecology (Tokyo, Japan)|April 1, 1995
EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic valueH Meden, D Marx, T Raab, et al.
In Vivo (Athens, Greece)|September 1, 1995
Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesionsM Korabiowska, U Brinck, J Mirecka, et al.
Zentralblatt Fur Chirurgie|January 1, 1992
[Breast carcinoma in pregnancy. Clinical, histological and immunohistochemical findings]H Meden, D Marx, W Rath, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancerD Marx, H Meden, T Ziemek, et al.
Pageof 26